Skip to main content

Abstract

Crystal arthropathies are a group of joint disorders due to deposition of crystals in and around joints which lead to joint destruction and soft tissue disturbances (swelling, redness, masses etc.). Clinical presentations of the different types of crystal arthropathies are often characteristic enough to differentiate them from each other, but mistakes can be made, leading to delayed or incorrect management. Gout is the most common form of crystal arthropathies. First identified by the Egyptians in 2640 BC and later by Hippocrates in the 5th century BC, who referred to as “the unwalkable disease”. Throughout history, gout has been associated with rich foods and excessive alcohol consumption and has been referred to as the “disease of kings”. Calcium pyrophosphate dihydrate disease (CPPD/pseudogout) and basic calcium phosphate (BCP/hydroxyapatite) are the two other forms of crystal arthropathies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Further Reading

  • Abhishek A, Doherty M. Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy. Rheum Dis Clin N Am. 2014;40(2):177–91.

    Article  Google Scholar 

  • Burns CM, Wortmann RL. Gout therapeutics: new drugs for an old disease. Lancet. 2010;377:165.

    Article  Google Scholar 

  • Cho NS, Lee BG, Rhee YG. Radiologic course of the calcific deposits in calcific tendinitis of the shoulder: does the initial radiologic aspect affect the final results? J Shoulder Elb Surg. 2010;19(2):267–72.

    Article  Google Scholar 

  • Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–52.

    Article  CAS  Google Scholar 

  • De Vera MA, Marcotte G, Rai S, et al. Medication adherence in gout: a systematic review. Arthritis Care Res. 2014;66:1551.

    Article  Google Scholar 

  • Filippou G, Filippucci E, Tardella M, et al. Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: an ultrasonographic study. Ann Rheum Dis. 2013;72(11):1836–9.

    Article  Google Scholar 

  • Gutierrez M, Di Geso L, Salaffi F, et al. Ultrasound detection of cartilage calcification at knee level in calcium pyrophosphate deposition disease. Arthritis Care Res (Hoboken). 2014;66(1):69–73.

    Article  CAS  Google Scholar 

  • Khanna D, Fitzgerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricaemia. Arthritis Care Res. 2012a;64:1431.

    Article  CAS  Google Scholar 

  • Khanna D, FitzGerald JD, Khanna PP, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res. 2012b;64:1447.

    Article  CAS  Google Scholar 

  • Loffler C, Sattler H, Peters L, Loffler U, Uppenkamp M, Bergner R. Distinguishing gouty arthritis from calcium pyrophosphate disease and other arthritides. J Rheumatol. 2015;42(3):513–20.

    Article  Google Scholar 

  • Neogi T, Jansen TA, Dalbeth N, et al. 2015 gout classification criteria. Arthritis Rheum. 2015;67(10):2557–68.

    Article  Google Scholar 

  • Rho YH, Zhu Y, Zhang Y, Reginato AM, Choi HK. Risk factors for pseudogout in the general population. Rheumatology (Oxford). 2012;51(11):2070–4.

    Article  Google Scholar 

  • Rosenthal AK. Basic calcium phosphate crystal-associated musculoskeletal syndromes: an update. Curr Opin Rheumatol. 2018;30(2):168–72.

    Article  CAS  Google Scholar 

  • Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374:2575–84.

    Article  CAS  Google Scholar 

  • Zhang W, Doherty M, Bardin T, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhling T, Watt I, Pascual E. European league against rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011a;70(4):563–70.

    Article  CAS  Google Scholar 

  • Zhang W, Doherty M, Pascual E, Barskova V, Guerne PA, Jansen TL, Leeb BF, Perez-Ruiz F, Pimentao J, Punzi L, Richette P, Sivera F, Uhlig T, Watt I, Bardin T. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011b;70(4):571–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pelechas, E., Kaltsonoudis, E., Voulgari, P.V., Drosos, A.A. (2019). Crystal Arthropathies. In: Illustrated Handbook of Rheumatic and Musculo-Skeletal Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-03664-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-03664-5_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-03663-8

  • Online ISBN: 978-3-030-03664-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics